PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19920821-1	2009	BACKGROUND: Both irinotecan (CPT-11) and S-1 are active against colorectal cancer; however, as S-1 is a prodrug of 5-fluorouracil (5-FU), 5-FU and its metabolites might inhibit the antitumour effect of CPT-11.	Irinotecan	17-27	proteasome 26S subunit, non-ATPase 1	Homo sapiens	95-98	
19920821-1	2009	BACKGROUND: Both irinotecan (CPT-11) and S-1 are active against colorectal cancer; however, as S-1 is a prodrug of 5-fluorouracil (5-FU), 5-FU and its metabolites might inhibit the antitumour effect of CPT-11.	Irinotecan	29-35	proteasome 26S subunit, non-ATPase 1	Homo sapiens	95-98	
19920821-1	2009	BACKGROUND: Both irinotecan (CPT-11) and S-1 are active against colorectal cancer; however, as S-1 is a prodrug of 5-fluorouracil (5-FU), 5-FU and its metabolites might inhibit the antitumour effect of CPT-11.	Irinotecan	202-208	proteasome 26S subunit, non-ATPase 1	Homo sapiens	41-44	
19920821-1	2009	BACKGROUND: Both irinotecan (CPT-11) and S-1 are active against colorectal cancer; however, as S-1 is a prodrug of 5-fluorouracil (5-FU), 5-FU and its metabolites might inhibit the antitumour effect of CPT-11.	Irinotecan	202-208	proteasome 26S subunit, non-ATPase 1	Homo sapiens	95-98